Víctor Fernández-Dueñas1, 2, Sergi Ferré3, Francisco Ciruela1, 2
1 Unitat de Farmacologia, DepartamentPatologia i Terapèutica Experimental, Facultat de Medicina, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain;
2 Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain;
3 Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA
This work was supported by MINECO/ISC III (SAF2014-55700-P and PIE14/00034), IWT (SBO-140028) and Fundació la Marató de TV3 (Grant 20152031) to FC. Also, FC and VFD belong to the “Neuropharmacology and Pain” accredited research group (Generalitat de Catalunya,2014 SGR1251), and by the intramural funds of the National Institute on Drug Abuse to SF.